Niklas Kouparanis

Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020.

Farmako GmbH operates as a holding company, which engages in the sale and distribution of pharmaceutical cannabis products. It also specializes in the research and development of new therapies using cannabis-based drugs. The company was founded by Niklas Kouparanis, Patrick Schmitt, and Sebastian Diemer on September 12, 2018 and is headquartered in Frankfurt, Germany.